1. Home
  2. PFS vs IDYA Comparison

PFS vs IDYA Comparison

Compare PFS & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFS
  • IDYA
  • Stock Information
  • Founded
  • PFS 1839
  • IDYA 2015
  • Country
  • PFS United States
  • IDYA United States
  • Employees
  • PFS N/A
  • IDYA N/A
  • Industry
  • PFS Savings Institutions
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFS Finance
  • IDYA Health Care
  • Exchange
  • PFS Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • PFS 2.5B
  • IDYA 2.2B
  • IPO Year
  • PFS N/A
  • IDYA 2019
  • Fundamental
  • Price
  • PFS $19.43
  • IDYA $23.15
  • Analyst Decision
  • PFS Strong Buy
  • IDYA Strong Buy
  • Analyst Count
  • PFS 5
  • IDYA 13
  • Target Price
  • PFS $22.60
  • IDYA $53.67
  • AVG Volume (30 Days)
  • PFS 522.3K
  • IDYA 890.1K
  • Earning Date
  • PFS 01-28-2025
  • IDYA 02-18-2025
  • Dividend Yield
  • PFS 4.92%
  • IDYA N/A
  • EPS Growth
  • PFS N/A
  • IDYA N/A
  • EPS
  • PFS 0.98
  • IDYA N/A
  • Revenue
  • PFS $526,013,000.00
  • IDYA $3,922,000.00
  • Revenue This Year
  • PFS N/A
  • IDYA N/A
  • Revenue Next Year
  • PFS $27.38
  • IDYA $273.42
  • P/E Ratio
  • PFS $19.93
  • IDYA N/A
  • Revenue Growth
  • PFS 13.26
  • IDYA N/A
  • 52 Week Low
  • PFS $13.07
  • IDYA $22.10
  • 52 Week High
  • PFS $22.24
  • IDYA $47.74
  • Technical
  • Relative Strength Index (RSI)
  • PFS 52.34
  • IDYA 39.49
  • Support Level
  • PFS $19.07
  • IDYA $22.10
  • Resistance Level
  • PFS $19.82
  • IDYA $24.06
  • Average True Range (ATR)
  • PFS 0.50
  • IDYA 1.04
  • MACD
  • PFS 0.14
  • IDYA -0.15
  • Stochastic Oscillator
  • PFS 81.07
  • IDYA 24.19

About PFS Provident Financial Services Inc

Provident Financial Services Inc is the holding company for The Provident Bank, a community-oriented bank. The Company's operations are solely in the financial services industry and include providing traditional banking and other financial services to its customers. The Company operates in the geographical regions of northern and central New Jersey, Queens and Nassau Counties in New York and eastern Pennsylvania. The Company has a single reporting segment for financial reporting purposes. The majority of the revenue-generating activities that are components of non-interest income are These revenue streams can generally be classified into three broad categories: wealth management revenue, insurance agency income, and banking service charges and other fees.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

Share on Social Networks: